ATH
Click for more information
11.1% 0.5¢ alterity therapeutics limited

Ann: Expanded ATH434 Phase 2 Clinical Development Program, page-7

  1. rising
    912 Posts.
    lightbulb Created with Sketch. 164
    clock Created with Sketch.
    19/10/21
    10:37
    Post #: 56899376
    We can all look forward to an announcement in March next year where ATH will announce that they look forward to initiating the trial in the second quarter of calendar year 2022.

    Pardon my pessimism but it’s a side effect of being a long term shareholder.
    ATH Price at posting: 3.1¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
ITM Fast-track assaying yields 182 g/t gold for iTech at new NT play
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
0.001(11.1%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $4.263K 916.0K

Buyers (Bids)

No. Vol. Price($)
58 69165915 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 38212524 21
View Market Depth
Last trade - 15.11pm 05/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.